|
1
|
Nelson BP, Treaba D, Goolsby C, Williams
S, Dewald G, Gordon L and Peterson LC: Surface immunoglobulin
positive lymphoblastic leukemia in adults; A genetic spectrum. Leuk
Lymphoma. 47:1352–1359. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karanu FN, Murdoch B, Miyabayashi T, Ohno
M, Koremoto M, Gallacher L, Wu D, Itoh A, Sakano S and Bhatia M:
Human homologues of Delta-1 and Delta-4 function as mitogenic
regulators of primitive human hematopoietic cells. Blood.
97:1960–1967. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li H, Hu H, Zhao Y, Chen X, Li W, Qiang W
and Xu D: Multifunctional aptamer-silver conjugates as theragnostic
agents for specific cancer cell therapy and fluorescence-enhanced
cell imaging. Anal Chem. 87:3736–3745. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yin J, He X, Wang K, Xu F, Shangguan J, He
D and Shi H: Label-free and turn-on aptamer strategy for cancer
cells detection based on a DNA-silver nanocluster fluorescence upon
recognition-induced hybridization. Anal Chem. 85:12011–12019. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xiong L, Zhang J, Yuan B, Dong X, Jiang X
and Wang Y: Global proteome quantification for discovering
imatinib-induced perturbation of multiple biological pathways in
K562 human chronic myeloid leukemia cells. J Proteome Res.
9:6007–6015. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu H, Xu S, He Z, Deng A and Zhu JJ:
Supersandwich cytosensor for selective and ultrasensitive detection
of cancer cells using aptamer-DNA concatamer-quantum dots probes.
Anal Chem. 85:3385–3392. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ellington AD and Szostak JW: In vitro
selection of RNA molecules that bind specific ligands. Nature.
346:818–822. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tuerk C and Gold L: Systematic evolution
of ligands by exponential enrichment: RNA ligands to bacteriophage
T4 DNA polymerase. Science. 249:505–510. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tan W, Donovan MJ and Jiang J: Aptamers
from cell-based selection for bioanalytical applications. Chem Rev.
113:2842–2862. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen H, Yuan F, Wang S, Xu J, Zhang Y and
Wang L: Aptamer-based sensing for thrombin in red region via
fluorescence resonant energy transfer between
NaYF4:Yb,Er upconversion nanoparticles and gold
nanorods. Biosens Bioelectron. 48:19–25. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vinkenborg JL, Mayer G and Famulok M:
Aptamer-based affinity labeling of proteins. Angew Chem Int Ed
Engl. 51:9176–9180. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiao Z and Farokhzad OC:
Aptamer-functionalized nanoparticles for medical applications:
Challenges and opportunities. ACS Nano. 6:3670–3676. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gong Q, Wang J, Ahmad KM, Csordas AT, Zhou
J, Nie J, Stewart R, Thomson JA, Rossi JJ and Soh HT: Selection
strategy to generate aptamer pairs that bind to distinct sites on
protein targets. Anal Chem. 84:5365–5371. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Famulok M, Hartig JS and Mayer G:
Functional aptamers and aptazymes in biotechnology, diagnostics,
and therapy. Chem Rev. 107:3715–3743. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang H, Zhang XB, Lv Y, Gong L, Wang R,
Zhu X, Yang R and Tan W: Functional DNA-containing nanomaterials:
Cellular applications in biosensing, imaging, and targeted therapy.
Acc Chem Res. 47:1891–1901. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shangguan D, Li Y, Tang Z, Cao ZC, Chen
HW, Mallikaratchy P, Sefah K, Yang CJ and Tan W: Aptamers evolved
from live cells as effective molecular probes for cancer study.
Proc Natl Acad Sci USA. 103:11838–11843. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang X and Tan W: Aptamers generated from
cell-SELEX for molecular medicine: A chemical biology approach. Acc
Chem Res. 43:48–57. 2010. View Article : Google Scholar :
|
|
18
|
Zhang M, Liu H, Chen L, Yan M, Ge L, Ge S
and Yu J: A disposable electrochemiluminescence device for
ultrasensitive monitoring of K562 leukemia cells based on aptamers
and ZnO@carbon quantum dots. Biosens Bioelectron. 49:79–85. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang FB, Rong Y, Fang M, Yuan JP, Peng CW,
Liu SP and Li Y: Recognition and capture of metastatic
hepatocellular carcinoma cells using aptamer-conjugated quantum
dots and magnetic particles. Biomaterials. 34:3816–3827. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sheng Z, Hu D, Zhang P, Gong P, Gao D, Liu
S and Cai L: Cation exchange in aptamer-conjugated CdSe
nanoclusters: A novel fluorescence signal amplification for cancer
cell detection. Chem Commun. 48:4202–4204. 2012. View Article : Google Scholar
|
|
21
|
Hu D, Zhang P, Gong P, Lian S, Lu Y, Gao D
and Cai L: A fast synthesis of near-infrared emitting CdTe/CdSe
quantum dots with small hydrodynamic diameter for in vivo imaging
probes. Nanoscale. 3:4724–4732. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Medintz IL, Uyeda HT, Goldman ER and
Mattoussi H: Quantum dot bioconjugates for imaging, labelling and
sensing. Nat Mater. 4:435–446. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee J, Kang HJ, Jang H, Lee YJ, Lee YS,
Ali BA, Al-Khedhairy AA and Kim S: Simultaneous imaging of two
different cancer biomarkers using aptamer-conjugated quantum dots.
Sens Basel. 15:8595–8604. 2015. View Article : Google Scholar
|
|
24
|
Alibolandi M, Abnous K, Ramezani M,
Hosseinkhani H and Hadizadeh F: Synthesis of
AS1411-aptamer-conjugated CdTe quantum dots with high fluorescence
strength for probe labeling tumor cells. J Fluoresc. 24:1519–1529.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mashinchian O, Johari-Ahar M, Ghaemi B,
Rashidi M, Barar J and Omidi Y: Impacts of quantum dots in
molecular detection and bioimaging of cancer. Bioimpacts.
4:149–166. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xing Y and Rao J: Quantum dot
bioconjugates for in vitro diagnostics & in vivo imaging.
Cancer biomarkers: Section. Dis Markers. 4:307–319. 2008.
|
|
27
|
Savla R, Taratula O, Garbuzenko O and
Minko T: Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin
conjugate for imaging and treatment of cancer. J Control Release.
153:16–22. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tada H, Higuchi H, Wanatabe TM and Ohuchi
N: In vivo real-time tracking of single quantum dots conjugated
with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res.
67:1138–1144. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu C, Liu J, Zhang P, Li J, Ji H, Yang X
and Wang K: A recognition-before-labeling strategy for sensitive
detection of lung cancer cells with a quantum dot-aptamer complex.
Analyst. 140:6100–6107. 2015. View Article : Google Scholar : PubMed/NCBI
|
